SWOG clinical trial number
S9619

Phase II Trial of Intraperitoneal Cisplatin and Intravenous and Intraperitoneal Paclitaxel in Women with Optimally-Debulked Stage III Epithelial Ovarian Cancer, Intergroup

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Phase II Trial of Intraperitoneal Cisplatin and Intravenous and Intraperitoneal Paclitaxel in Women with Optimally-Debulked Stage III Epithelial Ovarian Cancer, Intergroup
Activated
05/15/1996
Closed
05/15/1998

Publication Information Expand/Collapse

2003

Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: Results from an Intergroup phase II trial

ML Rothenberg;PY Liu;PS Braley;SP Wilczynski;EV Hannigan;S Wadler;G Stuart;C Jiang;M Markman;DS Alberts Journal of Clinical Oncology 21(7):1313-1319

2002

Excellent 2-year survival in women with optimally-debulked ovarian cancer treated with intraperitoneal and intravenous chemotherapy: a SWOG-ECOG-NCIC study (S9619)

ML Rothenberg;PY Liu;S Wilczynski;PS Braly;S Wadler;G Stuart;EV Hannigan;AJ Bonebrake;DS Alberts;M Markman Proc of the American Society of Clinical Oncology 21:203a(#809)